BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15229891)

  • 1. Molecular determinants of thapsigargin binding by SERCA Ca2+-ATPase: a computational docking study.
    Paula S; Ball WJ
    Proteins; 2004 Aug; 56(3):595-606. PubMed ID: 15229891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of various amino acid 256 mutations on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase function and their role in the cellular adaptive response to thapsigargin.
    Yu M; Lin J; Khadeer M; Yeh Y; Inesi G; Hussain A
    Arch Biochem Biophys; 1999 Feb; 362(2):225-32. PubMed ID: 9989931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of sarco/endoplasmic reticulum calcium ATPase inhibition by hydroquinone-based compounds.
    Lape M; Elam C; Versluis M; Kempton R; Paula S
    Proteins; 2008 Feb; 70(3):639-49. PubMed ID: 17879345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locating the thapsigargin-binding site on Ca(2+)-ATPase by cryoelectron microscopy.
    Young HS; Xu C; Zhang P; Stokes DL
    J Mol Biol; 2001 Apr; 308(2):231-40. PubMed ID: 11327764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of two novel subpicomolar sarco/endoplasmatic reticulum Ca2+-ATPase inhibitors designed by an analysis of the binding site of thapsigargin.
    Søhoel H; Liljefors T; Ley SV; Oliver SF; Antonello A; Smith MD; Olsen CE; Isaacs JT; Christensen SB
    J Med Chem; 2005 Nov; 48(22):7005-11. PubMed ID: 16250659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase.
    Singh P; Mhaka AM; Christensen SB; Gray JJ; Denmeade SR; Isaacs JT
    J Med Chem; 2005 Apr; 48(8):3005-14. PubMed ID: 15828839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand docking in the gastric H+/K+-ATPase: homology modeling of reversible inhibitor binding sites.
    Kim CG; Watts JA; Watts A
    J Med Chem; 2005 Nov; 48(23):7145-52. PubMed ID: 16279772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical assessment of docking programs and scoring functions.
    Warren GL; Andrews CW; Capelli AM; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS
    J Med Chem; 2006 Oct; 49(20):5912-31. PubMed ID: 17004707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific structural requirements for the inhibitory effect of thapsigargin on the Ca2+ ATPase SERCA.
    Xu C; Ma H; Inesi G; Al-Shawi MK; Toyoshima C
    J Biol Chem; 2004 Apr; 279(17):17973-9. PubMed ID: 14970206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-mediated interactions influence the binding of thapsigargin to sarco/endoplasmic reticulum calcium adenosinetriphosphatase.
    Paulsen ES; Villadsen J; Tenori E; Liu H; Bonde DF; Lie MA; Bublitz M; Olesen C; Autzen HE; Dach I; Sehgal P; Nissen P; Møller JV; Schiøtt B; Christensen SB
    J Med Chem; 2013 May; 56(9):3609-19. PubMed ID: 23574308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical roles of hydrophobicity and orientation of side chains for inactivation of sarcoplasmic reticulum Ca2+-ATPase with thapsigargin and thapsigargin analogs.
    Winther AM; Liu H; Sonntag Y; Olesen C; le Maire M; Soehoel H; Olsen CE; Christensen SB; Nissen P; Møller JV
    J Biol Chem; 2010 Sep; 285(37):28883-92. PubMed ID: 20551329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the S3 stalk segment in the thapsigargin concentration dependence of sarco-endoplasmic reticulum Ca2+ ATPase inhibition.
    Zhong L; Inesi G
    J Biol Chem; 1998 May; 273(21):12994-8. PubMed ID: 9582334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban.
    Asahi M; Sugita Y; Kurzydlowski K; De Leon S; Tada M; Toyoshima C; MacLennan DH
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5040-5. PubMed ID: 12692302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding to P-type ATPases as revealed by biochemical, spectroscopic, and crystallographic experiments.
    Kubala M
    Proteins; 2006 Jul; 64(1):1-12. PubMed ID: 16649212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors bound to Ca(2+)-free sarcoplasmic reticulum Ca(2+)-ATPase lock its transmembrane region but not necessarily its cytosolic region, revealing the flexibility of the loops connecting transmembrane and cytosolic domains.
    Montigny C; Picard M; Lenoir G; Gauron C; Toyoshima C; Champeil P
    Biochemistry; 2007 Dec; 46(51):15162-74. PubMed ID: 18052080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interhelical hydrogen bonds in transmembrane region are important for function and stability of Ca2+-transporting ATPase.
    Adamian L; Liang J
    Cell Biochem Biophys; 2003; 39(1):1-12. PubMed ID: 12835525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
    Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
    Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes in the calcium pump accompanying the dissociation of calcium.
    Toyoshima C; Nomura H
    Nature; 2002 Aug; 418(6898):605-11. PubMed ID: 12167852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of docking performance: comparative data on docking algorithms.
    Kontoyianni M; McClellan LM; Sokol GS
    J Med Chem; 2004 Jan; 47(3):558-65. PubMed ID: 14736237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.